13F

Stock

Citius Oncology, Inc.

CTOR · held by 14 managers

Reported value

$8.83M

Holders

14

+1 new · −6 exited

Holders’ est. mark

−$2.3M

Price effect on 11 books still in the name

Largest holder

$5.7M

ARMISTICE CAPITAL, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ARMISTICE CAPITAL, LLC9.19M$5.7M−$2.12MAdded$112.1K
BANK OF AMERICA CORP /DE/3.84M$2.37M−$82Added$2.37M
VANGUARD CAPITAL MANAGEMENT LLC534.8K$331.6KHeld
GEODE CAPITAL MANAGEMENT, LLC264.7K$164.1K−$83.6KCut−$55.9K
VANGUARD FIDUCIARY TRUST CO121.9K$75.6KHeld
IFP Advisors, Inc107.4K$66.6K−$33.2KCut−$20.8K
BlackRock, Inc.47.5K$29.4K−$8.49KAdded$7.07K
NORTHERN TRUST CORP45.7K$28.4K−$17.4KCut−$17.4K
State Street42.9K$26.6K−$16.3KCut−$16.3K
UBS Group AG36.8K$22.8K−$8.16KAdded$1.38K
Arkadios Wealth Advisors11.7K$7.23K−$4.43KCut−$4.43K
OSAIC HOLDINGS, INC.10.1K$6.28K−$3.85KCut−$5.15K
Caitong International Asset Management Co., Ltd1$1New
ROYAL BANK OF CANADA186$0$0Held

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.